MYC and hematopoietic and lymphoid cell neoplasm: Moreover, this regulation shows a broader mechanism of action of NSD3S, as MYC acts as a driver in multiple solid and hematological cancers (Vita and Henriksson, 2006) and this study suggests a regulation of MYC by NSD3S in various cellular environments.